ScholarIQanswers from OpenAlex

Eculizumab and Complement Activation in Anti−glomerular Basement Membrane Disease

PaperCitations, authors & open-access status

Eculizumab and Complement Activation in Anti−glomerular Basement Membrane Disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Eculizumab and Complement Activation in Anti−glomerular Basement Membrane Disease have?

ScholarIQcitation count

Eculizumab and Complement Activation in Anti−glomerular Basement Membrane Disease has 19 citations in the OpenAlex counts ScholarIQ stores.

When was Eculizumab and Complement Activation in Anti−glomerular Basement Membrane Disease published?

ScholarIQyear

Eculizumab and Complement Activation in Anti−glomerular Basement Membrane Disease has 2021 year in the ScholarIQ index.

What is the open-access status of Eculizumab and Complement Activation in Anti−glomerular Basement Membrane Disease?

ScholarIQoa status

Eculizumab and Complement Activation in Anti−glomerular Basement Membrane Disease has gold oa status in the ScholarIQ index.

What is the DOI of Eculizumab and Complement Activation in Anti−glomerular Basement Membrane Disease?

ScholarIQdoi

The DOI for Eculizumab and Complement Activation in Anti−glomerular Basement Membrane Disease is on the source record.

What is the PMID of Eculizumab and Complement Activation in Anti−glomerular Basement Membrane Disease?

ScholarIQpmid

The PMID for Eculizumab and Complement Activation in Anti−glomerular Basement Membrane Disease is on the source record.

What is the OpenAlex record for Eculizumab and Complement Activation in Anti−glomerular Basement Membrane Disease?

ScholarIQopenalex

The OpenAlex for Eculizumab and Complement Activation in Anti−glomerular Basement Membrane Disease is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial